Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Apr
6
2023
 News Alert: Public Consultation on the EU’s Tobacco Products Legislation: Comment Period Open Until May 16, 2023 Keller and Heckman LLP
Apr
6
2023
 DOC’s Bureau of Economic Analysis Releases Report on Developing a National Measure of the Economic Contributors of the Bioeconomy Bergeson & Campbell, P.C.
Apr
6
2023
 FDA Announces First-Ever AI/ML Medical Device Draft Guidance Nelson Mullins
Apr
5
2023
 D’Addario v. Johnson & Johnson – New Jersey Federal Court Addresses Express Pre-Emption In Class III Medical Device Case Sills Cummis & Gross P.C.
Apr
5
2023
 “All Fruit” Jelly Label Continues to be Challenged in New York Federal Court Keller and Heckman LLP
Apr
5
2023
 DOD Publishes Biomanufacturing Strategy and RFI on Biomanufactured Products and Process Capabilities Bergeson & Campbell, P.C.
Apr
4
2023
 Is CMS Ignoring the Realities of Biopharmaceutical Costs? Epstein Becker & Green, P.C.
Apr
4
2023
 COVID-19 Related Medical Devices: FDA Finalizes Transition Plan Guidance Foley & Lardner LLP
Apr
4
2023
 Unpacking Averages: FDA FOIA Response Times by Topic of Request Epstein Becker & Green, P.C.
Apr
4
2023
 Lawsuit Forces Early Release of NTP’s Draft Report on Fluoride, and its Potential Association with Neurodevelopment and Cognition ArentFox Schiff LLP
Apr
4
2023
 White House Report Identifies Precision Medicine for Future R & D Investment Foley & Lardner LLP
Apr
4
2023
 FDA Holds Joint Meeting on Food Safety with Mexican Counterparts Keller and Heckman LLP
Apr
3
2023
 White House OSTP Outlines Goals for U.S. Biotechnology and Manufacturing Bergeson & Campbell, P.C.
Apr
3
2023
 Editors’ Roundtable: Predictions About the Upcoming Farm Bill Bradley Arant Boult Cummings LLP
Apr
3
2023
 FDA Publishes Framework for Digital Health Technologies in Clinical Trials Foley & Lardner LLP
Apr
3
2023
 EPA Proposes National Primary Drinking Water Regulation to Set Stringent Limits on PFAS in Drinking Water, Including Four Newly Targeted Substances Hunton Andrews Kurth
Apr
3
2023
 New Lawsuit Comes Amidst Push to Exclude Juice From “Healthy” Definition Keller and Heckman LLP
Mar
31
2023
 McDermott+Consulting Check-Up: March 31, 2023 McDermott Will & Emery
Mar
31
2023
 New Cosmetics Regulatory Scheme to Reshape Industry's Relationship with FDA McDermott Will & Emery
Mar
30
2023
 Medical Device Developers Now Required to Incorporate Cybersecurity Plans into FDA Premarket Submissions for “Cyber” Devices Mintz
Mar
30
2023
 Food and Chemicals Unpacked: Laying Claim: FTC’s Green Guides Keller and Heckman LLP
Mar
30
2023
 Use of Salt Substitutes Expanded to Help Lower Sodium Intake Keller and Heckman LLP
Mar
30
2023
 The South Korean Food Authority Releases New Rules and Policies Supporting the Development of the Alternative Protein Industry Keller and Heckman LLP
Mar
30
2023
 The Short-Term Consequences of Alabama’s Cannabis Social Equity Policy Bradley Arant Boult Cummings LLP
Mar
29
2023
 FDA Publishes Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula Market Keller and Heckman LLP
Mar
29
2023
 FDA Issues First Untitled Letter of the Year to HCT/P Manufacturer Sheppard, Mullin, Richter & Hampton LLP
Mar
29
2023
 The BioPharma Patent Cliff: 2023 and Beyond Foley & Lardner LLP
Mar
28
2023
 FDA Revamps Guidance Concerning Use of Electronic Systems, Records, and Signatures in Clinical Investigations Nelson Mullins
Displaying 1905 - 1932 of 11749
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins